Aims-To assess keratin profiles from smears of malignant and contralateral normal oral mucosa as part of the development of a screening procedure for oral cancer based on exfoliative cytology. Methods-Smears were taken from oral cancers (confirmed by biopsy) and from the contralateral site of 20 patients. Using a panel of antikeratin antibodies, the keratins expressed by these cells were identified using a standard immunocytochemical technique (Vectastain) and assessed on a 3 point scale.
Despite the fact that oral cancer can be cured if treated early enough,7 the 5 year survival (about 35%)8 has not really improved with advances in surgery, radiotherapy, and chemotherapy. 9 The main reason is probably the late presentation of these tumours.'°1 1 In turn this may be due to: (i) the asymptomatic nature of the early lesion'0; (ii) lack of self examination by patients'2 "; (iii) misdiagnosis by clinician'O-'2; and (iv) the patient's fear." 12 These obstacles have to be overcome if the prognosis is to improve.
Recent calls for a screening procedure for oral cancer still rely on subjective assessment by the clinician as to whether the mucosa appears clinically malignant or not.'4 15 Recent advances in the quantitative assessment of oral cytology16-20 may offer a suitable technique for such screening, analogous to the screening procedure based on exfoliative cytology for cervical cancer, a disease which may have a similar incidence to oral cancer.'4 Heavily keratinised oral lesions make it difficult to gain a representative sample of the underlying lesion, but this is offset by their relatively low malignant transformation rateabout 2%.21 Far more worrying are the speckled leucoplakias and erythroplakias which are reported to undergo malignant change more frequently. These lesions are amenable to sampling using exfoliative cytology. Not all general practitioners would biopsy the oral mucosa and they may be more inclined to smear an abnormality of the mucosa. Furthermore, in patients who are under review following treatment of an oral squamous cell carcinoma or in patients who have widespread instability of the oral mucosa, repeat biopsies at every review are not practicable. Such patients would soon fail to attend for review. Exfoliative cytology permits the frequent sampling of such sites with minimal inconvenience to the patient. This forms part of the overall management of our patients treated in Tayside.
As well as assessment of nuclear status, exfoliative cytology samples can be assessed for differentiation status England), and fixed using a commercially available spray fixative containing isopropyl alcohol and polyethylene glycol (Vale Smear Fix, Vale Laboratories, England). Smears were then stored at -70°C until required. Table 1 shows the range of monoclonal antibodies used to identify the cytokeratin profile (together with dilutions, and source). Goat serum was used as the negative control. Four "wells" were created on each plain glass slide with the aid of a wax pen (PAP pen, Agar Scientific Ltd., England) thus allowing up to four antibodies to be used on each smear.
A standard protocol was followed using avidin biotin visualisation" (Vectastain, Vector Labs., Peterborough, England). Briefly the smears were thawed, fixed in acetone 
LesFOM P (100%) for 5 minutes, then air dried at room temperature. After incubation with the antibodies shown the peroxidase label distribution was visualised using diaminobenzidine tetrahydrochloride (DAB) substrate. The smears were then lightly counterstained with Mayer's haematoxylin, dehydrated, and mounted in DPX. The presence of a particular keratin was then assessed according to the number of brown ("positive") cells present, on a 3 point scale: 0 = no cells positive; 1 = few cells positive among many negative cells; 2 = many positive cells. All smears were graded by one author (GRO). Intraobserver error was randomly checked to assess reproducibility. The entire "well" exposed to a particular antikeratin antibody was scanned for the presence of positively stained cells.
The criteria used for selection of patients reported in this study were that: all should have had histological evidence of carcinoma, smears had been taken from tumour and contralateral sites; and that cytokeratin profiles were available. From our cohort of patients, sequentially the first 20 satisfying these criteria were admitted to the series. By chance this resulted in roughly equal numbers from four different sites in the mouth, including the rare site of the soft palate.
Results
The results for expression of a particular keratin in both the lesional smear (les) and the contralateral normal mucosal smear (N) are given in table 2 and include results for LP34, which acted as the positive control. The results for smears from these two sites in each patient were compared using X2 analysis. A significant difference between normal and malignant mucosal smears was found for keratin 8/18 (p <0Q01), keratin 19 (p < 0 01), and keratin 13 (p < 0-05). For keratin 8/18, the scores for CAM5-2 and LE41/LE61 were averaged for statistical comparison of normal and lesional smears. Although 20 patients were assessed, cells were not always present within the "well" dedicated to that particular antikeratin antibody. Variations in cell density between individual "wells" in one smear and between cases were apparent. When there were insufficient cells to grade the smear no grade was given. cally normal oral mucosa.
Although it is recommended that for t identification of a particular keratin mc than one antibody recognising that kera should be used,24 there Plain glass slides were used at first, with "wells" created by the use of a wax pen. These wells also had the added advantage of limiting the amount of reagent used, and thus the expense of the procedure. However, positive steps had to be taken to avoid bias caused by uneven cell spreading across the slide because the antibodies always followed the same order; those near the boundary of the slide (the marker for keratin 10, LH1) were more likely not to contain sufficient cells on which to grade the expression of that particular keratin. Sampling errors will prejudice the results and possibly limit the value of exfoliative cytology but must be accepted within the limits of the technique. Empty wells occurred in 29 of 240 wells and were excluded from statistical analysis. We have now modified this to use 4-well slides (Hendley Essex), instead of plain slides. Thus the sample instrument makes contact with all four sites that will subsequently receive an antikeratin antibody, which greatly increases the likelihood of cells being present. These smears were taken with the Cytobrush which we have found superior to the traditional wooden spatula.32 Another factor to consider with regard to cell yield is that of site. In our expethe rience the hard palate is the site most fre-:re quently associated with a poor cell harvest.32 tin
The keratins showing the most significant the difference between smears from normal and lus malignant mucosa were the simple keratins 8, ed. 18, and 19. This is perhaps not too surpris-C8, ing, given that for normal oral mucosa the es) other keratins assessed (keratins 10 and 13) the are expressed throughout the suprabasal ful region of keratinsed (K10) and non-kerailts tinised (K13) regions in the oral cavity.253' ;ed
In tissue biopsy specimens it has been )se claimed that well differentiated oral carcinons, mas express variable mixtures of keratins 10 ger and 13. 
